Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

C4 Therapeutics (CCCC) Tax Provisions (2019 - 2024)

C4 Therapeutics (CCCC) has 4 years of Tax Provisions data on record, last reported at $131000.0 in Q4 2024.

  • For Q4 2024, Tax Provisions fell 53.21% year-over-year to $131000.0; the TTM value through Dec 2024 reached $131000.0, down 89.79%, while the annual FY2025 figure was $100000.0, 23.66% down from the prior year.
  • Tax Provisions reached $131000.0 in Q4 2024 per CCCC's latest filing, down from $280000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $1.0 million in Q3 2023 and bottomed at -$168000.0 in Q2 2020.
  • Average Tax Provisions over 3 years is $112571.4, with a median of -$124000.0 recorded in 2020.
  • Peak YoY movement for Tax Provisions: tumbled 125.69% in 2020, then crashed 53.21% in 2024.
  • A 3-year view of Tax Provisions shows it stood at -$124000.0 in 2020, then surged by 325.81% to $280000.0 in 2023, then plummeted by 53.21% to $131000.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Tax Provisions were $131000.0 in Q4 2024, $280000.0 in Q4 2023, and $1.0 million in Q3 2023.